Clinical trials
Glioblastoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
194 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 6 |
| 2007 | 5 |
| 2008 | 7 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 8 |
| 2013 | 4 |
| 2014 | 7 |
| 2015 | 6 |
| 2016 | 10 |
| 2017 | 9 |
| 2018 | 16 |
| 2019 | 18 |
| 2020 | 22 |
| 2021 | 21 |
| 2022 | 15 |
| 2023 | 10 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 194 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huashan Hospital | 6 |
| Beijing Tiantan Hospital | 5 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 4 |
| Sun Yat-sen University | 4 |
| NovoCure Ltd. | 3 |
| Shandong Cancer Hospital and Institute | 3 |
| TransMolecular | 3 |
| Adnexus, A Bristol-Myers Squibb R&D Company | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Assistance Publique Hopitaux De Marseille | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 194 |
| Glioma | 43 |
| Brain Neoplasms | 34 |
| Astrocytoma | 27 |
| Gliosarcoma | 21 |
| Central Nervous System Neoplasms | 16 |
| Oligodendroglioma | 16 |
| Neoplasms | 9 |
| Recurrence | 7 |
| Ependymoma | 5 |
Trials
Showing 1 to 25 of 194. Each trial links to its page on Pharma Observatory.
94 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.